Related Experiment Video
Updated: May 8, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications
Matthias Walter1, Stefan Altermatt, Claudia Furrer
1Neuro-Urology, Spinal Cord Injury Centre & Research, University of Zurich, Balgrist University Hospital , Zurich , Switzerland .
Insights
Intrathecal baclofen (ITB) therapy effectively reduces lower limb spasticity in children with congenital brain injuries. However, close patient monitoring is crucial due to a high incidence of complications, particularly early after implantation.
Area of Science:
- Pediatric Neurology
- Neurosurgery
- Rehabilitation Medicine
Background:
- Severe spasticity in children with congenital brain injuries significantly impacts motor function and quality of life.
- Intrathecal baclofen (ITB) therapy is a potential treatment option for refractory spasticity.
Purpose of the Study:
- To evaluate the clinical effectiveness of ITB therapy in reducing spasticity in pediatric patients.
- To determine the incidence and types of complications associated with ITB therapy in this population.
Main Methods:
- Retrospective review of medical charts for 15 pediatric patients with congenital brain injuries.
- Patients received ITB implantation for severe spasticity between 2003 and 2009.
- Data analysis focused on changes in spasticity (Modified Ashworth Scale) and complication rates.
Main Results:
- ITB therapy significantly decreased lower limb spasticity (p < 0.05) with increased baclofen dosage (p = 0.001).
- A significant increase in Cobb angle was observed in patients with pre-existing scoliosis (p < 0.05).
- Six patients (40%) experienced 10 complications (9 device-related, 1 accidental), primarily within three years post-implantation.
Conclusions:
- Intrathecal baclofen is an effective treatment for reducing lower limb spasticity in pediatric patients.
- The high rate of complications necessitates vigilant monitoring, especially during the early post-operative phase.
Objective:
To investigate clinical efficacy and incidence of complications regarding intrathecal baclofen (ITB) therapy in children.
Methods:
Retrospective medical chart review of 15 paediatric patients with congenital brain injuries who underwent ITB implantation for treatment of severe spasticity between 2003 and 2009.
Results:
Compared to the preoperative state, ITB therapy significantly reduced spasticity of lower limbs with corresponding decrease of the modified Ashworth scale (p < 0.05), while baclofen dosage increased (p = 0.001). Cobb angle of patients with scoliosis prior to ITB therapy (n = 8) increased significantly (p < 0.05) during follow-up. Overall, 10 complications (nine device related and one accidental) were found in six patients (40%), mostly emerging within the first three years after implantation.
Conclusion:
Intrathecal baclofen is an effective therapy option for paediatric patients to significantly reduce spasticity of lower limbs. The high incidence of complications implicates the need for a close monitoring of the patients especially in the early post-operative period.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
